Bone Properties in Hypoparathyroidism: Effects of PTH

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

January 31, 2011

Study Completion Date

June 30, 2014

Conditions
Hypoparathyroidism
Interventions
DRUG

PTH

Trial Locations (1)

10032

Columbia University, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

John P. Bilezikian

OTHER

NCT00473265 - Bone Properties in Hypoparathyroidism: Effects of PTH | Biotech Hunter | Biotech Hunter